Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1689-1392
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro ; volume:26 ; number:1 ; day:21 ; month:10 ; year:2021 ; pages:1-15 ; date:12.2021
Cellular & molecular biology letters ; 26, Heft 1 (21.10.2021), 1-15, 12.2021
- Creator
-
Uruski, Paweł
Sepetowska, Agnieszka
Konieczna, Corinna
Pakuła, Martyna
Wyrwa, Michał
Tussupkaliyev, Akylbek
Tykarski, Andrzej
Mikuła-Pietrasik, Justyna
Książek, Krzysztof
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s11658-021-00287-4
- URN
-
urn:nbn:de:101:1-2022011421210233430916
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Uruski, Paweł
- Sepetowska, Agnieszka
- Konieczna, Corinna
- Pakuła, Martyna
- Wyrwa, Michał
- Tussupkaliyev, Akylbek
- Tykarski, Andrzej
- Mikuła-Pietrasik, Justyna
- Książek, Krzysztof
- SpringerLink (Online service)
Other Objects (12)
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
Die Behandlung des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Paclitaxel und Carboplatin
Einfluss von Paclitaxel und Carboplatin auf das Hitzeschockprotein 27 in Ovarialkarzinomzellen
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
Die Behandlung des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Paclitaxel und Carboplatin
Einfluss von Paclitaxel und Carboplatin auf das Hitzeschockprotein 27 in Ovarialkarzinomzellen
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
Die Behandlung des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Paclitaxel und Carboplatin
Einfluss von Paclitaxel und Carboplatin auf das Hitzeschockprotein 27 in Ovarialkarzinomzellen
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Principles of dormancy evident in high-grade serous ovarian cancer